WO2008017752A3 - Extrait d ' eucalyptus, son procede de preparation et ses utilisations therapeutiques - Google Patents
Extrait d ' eucalyptus, son procede de preparation et ses utilisations therapeutiques Download PDFInfo
- Publication number
- WO2008017752A3 WO2008017752A3 PCT/FR2007/001309 FR2007001309W WO2008017752A3 WO 2008017752 A3 WO2008017752 A3 WO 2008017752A3 FR 2007001309 W FR2007001309 W FR 2007001309W WO 2008017752 A3 WO2008017752 A3 WO 2008017752A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- isobutyl
- substituent
- therapeutic uses
- eucalyptus extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2007283529A AU2007283529A1 (en) | 2006-08-01 | 2007-07-27 | Eucalyptus extract, method of preparation and therapeutic uses thereof |
JP2009522297A JP2010500974A (ja) | 2006-08-01 | 2007-07-27 | 新規のユーカリ抽出物、その調製方法およびその治療利用法 |
BRPI0714863-1A BRPI0714863A2 (pt) | 2006-08-01 | 2007-07-27 | extrato de eucalipto, processo de preparo e utilizaÇÕes terapÊuticas do mesmo |
MX2009000673A MX2009000673A (es) | 2006-08-01 | 2007-07-27 | Nuevo extracto de eucalipto, su procedimiento de preparacion y sus utilizaciones terapeuticas. |
US12/309,754 US20090324754A1 (en) | 2006-08-01 | 2007-07-27 | Eucalyptus extract, method of preparation and therapeutic uses thereof |
CA002659162A CA2659162A1 (fr) | 2006-08-01 | 2007-07-27 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
NZ574429A NZ574429A (en) | 2006-08-01 | 2007-07-27 | New eucalyptus extract, method of preparation and therapeutic uses thereof |
EP07823364A EP2049133A2 (fr) | 2006-08-01 | 2007-07-27 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
TN2009000018A TN2009000018A1 (fr) | 2006-08-01 | 2009-01-19 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
IL196788A IL196788A0 (en) | 2006-08-01 | 2009-01-29 | New eucalyptus extract, method of preparation and therapeutic uses thereof |
NO20090951A NO20090951L (no) | 2006-08-01 | 2009-03-02 | Nytt eukalyptusekstrakt, fremgangsmate for fremstilling og terapeutiske anvendelser derav |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0607201A FR2904557B1 (fr) | 2006-08-01 | 2006-08-01 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
FR0607201 | 2006-08-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008017752A2 WO2008017752A2 (fr) | 2008-02-14 |
WO2008017752A3 true WO2008017752A3 (fr) | 2008-04-10 |
Family
ID=37708427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2007/001309 WO2008017752A2 (fr) | 2006-08-01 | 2007-07-27 | Extrait d ' eucalyptus, son procede de preparation et ses utilisations therapeutiques |
Country Status (20)
Country | Link |
---|---|
US (1) | US20090324754A1 (fr) |
EP (1) | EP2049133A2 (fr) |
JP (1) | JP2010500974A (fr) |
KR (1) | KR20090034401A (fr) |
CN (1) | CN101511378A (fr) |
AR (1) | AR062165A1 (fr) |
AU (1) | AU2007283529A1 (fr) |
BR (1) | BRPI0714863A2 (fr) |
CA (1) | CA2659162A1 (fr) |
FR (1) | FR2904557B1 (fr) |
IL (1) | IL196788A0 (fr) |
MA (1) | MA30592B1 (fr) |
MX (1) | MX2009000673A (fr) |
NO (1) | NO20090951L (fr) |
NZ (1) | NZ574429A (fr) |
RU (1) | RU2445112C2 (fr) |
TN (1) | TN2009000018A1 (fr) |
TW (1) | TW200820961A (fr) |
UA (1) | UA99598C2 (fr) |
WO (1) | WO2008017752A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926547B1 (fr) * | 2008-01-18 | 2010-04-23 | Pf Medicament | 5-°1-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h- cyclopropa°a!naphtalen-4-yl)-3-methylbutyl!-2,4,6-trihydroxy -1,3-benzenedicarboxaldehyde en tant que medicaments. |
JP5602346B2 (ja) | 2008-06-17 | 2014-10-08 | 株式会社ロッテ | ユーカリ抽出物の調製方法 |
GB2465228A (en) * | 2008-11-15 | 2010-05-19 | Athena Health Patents Inc | Analogues of phloroglucinols from eucalyptus plant varieties and related compounds and their use in treating neurodegenerative disorders |
CN102085169B (zh) * | 2011-01-30 | 2012-08-29 | 广州中涵生物科技有限公司 | 一种使黑头溶解同步收细毛孔的制剂 |
PT106278B (pt) * | 2012-04-26 | 2018-01-03 | Raiz Inst De Investigação Da Floresta E Papel | Método para a obtenção de um extrato rico em ácidos triterpénicos a partir da casca de eucalipto |
KR102115037B1 (ko) * | 2013-12-04 | 2020-05-25 | 코웨이 주식회사 | 상고머리 야테 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물 |
CN106231923A (zh) * | 2013-12-18 | 2016-12-14 | 斯拉毕思科股份公司 | 类囊体降低对可口食物欲望的用途 |
CN109475586A (zh) | 2016-06-29 | 2019-03-15 | 康纳塞斯创新公司 | 脱羧的大麻树脂、其用途和制备其的方法 |
CN109172554A (zh) * | 2018-09-06 | 2019-01-11 | 淮安安莱生物科技有限公司 | 大果桉醛c在制备治疗人肝癌的药物方面的应用 |
KR102212193B1 (ko) | 2019-07-15 | 2021-02-03 | 박경호 | 인동등 및 유칼립투스 추출물을 유효성분으로 포함하는 인지기능장애 예방 또는 치료용 조성물 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2329297A1 (fr) * | 1975-10-29 | 1977-05-27 | Rougier Yves | Inhalateur buccal |
JPH08198765A (ja) * | 1995-01-31 | 1996-08-06 | Hayami Kinugawa | 鎮痛用医薬組成物 |
US20030031735A1 (en) * | 2000-01-18 | 2003-02-13 | Nagaoka Perfumery Co., Ltd | Anti-obestic composition |
WO2003053336A2 (fr) * | 2001-12-19 | 2003-07-03 | The Quigley Corporation | Procedes de traitement de malaises neurovasculaires peripheriques |
JP2005272431A (ja) * | 2004-03-24 | 2005-10-06 | Yukio Kitagawa | アロマセラピー品 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3365782B2 (ja) * | 1990-11-22 | 2003-01-14 | 株式会社ロッテ | 新規マクロカルパール類及びその製造法 |
DE4447336C2 (de) * | 1994-12-31 | 1996-12-19 | Goebel Hartmut J Dr Med Habil | Verwendung eines Gemisches aus Cineol und Menthol |
JPH11137232A (ja) * | 1997-08-02 | 1999-05-25 | Ever Bright Ind Corp | ハーブ製品 |
JP4809980B2 (ja) * | 2000-01-18 | 2011-11-09 | 長岡香料株式会社 | 抗動脈硬化症剤 |
JP4979181B2 (ja) * | 2003-01-31 | 2012-07-18 | 株式会社ヤクルト本社 | グリケーション阻害剤及びその利用 |
-
2006
- 2006-08-01 FR FR0607201A patent/FR2904557B1/fr not_active Expired - Fee Related
-
2007
- 2007-07-27 RU RU2009107166/15A patent/RU2445112C2/ru not_active IP Right Cessation
- 2007-07-27 UA UAA200901761A patent/UA99598C2/ru unknown
- 2007-07-27 CN CNA2007800334763A patent/CN101511378A/zh active Pending
- 2007-07-27 WO PCT/FR2007/001309 patent/WO2008017752A2/fr active Application Filing
- 2007-07-27 CA CA002659162A patent/CA2659162A1/fr not_active Abandoned
- 2007-07-27 NZ NZ574429A patent/NZ574429A/en not_active IP Right Cessation
- 2007-07-27 US US12/309,754 patent/US20090324754A1/en not_active Abandoned
- 2007-07-27 AU AU2007283529A patent/AU2007283529A1/en not_active Abandoned
- 2007-07-27 BR BRPI0714863-1A patent/BRPI0714863A2/pt not_active IP Right Cessation
- 2007-07-27 JP JP2009522297A patent/JP2010500974A/ja active Pending
- 2007-07-27 KR KR1020097004185A patent/KR20090034401A/ko not_active Application Discontinuation
- 2007-07-27 EP EP07823364A patent/EP2049133A2/fr not_active Withdrawn
- 2007-07-27 MX MX2009000673A patent/MX2009000673A/es not_active Application Discontinuation
- 2007-07-31 TW TW096127881A patent/TW200820961A/zh unknown
- 2007-08-01 AR ARP070103382A patent/AR062165A1/es not_active Application Discontinuation
-
2009
- 2009-01-19 TN TN2009000018A patent/TN2009000018A1/fr unknown
- 2009-01-20 MA MA31575A patent/MA30592B1/fr unknown
- 2009-01-29 IL IL196788A patent/IL196788A0/en unknown
- 2009-03-02 NO NO20090951A patent/NO20090951L/no not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2329297A1 (fr) * | 1975-10-29 | 1977-05-27 | Rougier Yves | Inhalateur buccal |
JPH08198765A (ja) * | 1995-01-31 | 1996-08-06 | Hayami Kinugawa | 鎮痛用医薬組成物 |
US20030031735A1 (en) * | 2000-01-18 | 2003-02-13 | Nagaoka Perfumery Co., Ltd | Anti-obestic composition |
WO2003053336A2 (fr) * | 2001-12-19 | 2003-07-03 | The Quigley Corporation | Procedes de traitement de malaises neurovasculaires peripheriques |
JP2005272431A (ja) * | 2004-03-24 | 2005-10-06 | Yukio Kitagawa | アロマセラピー品 |
Non-Patent Citations (14)
Title |
---|
AMAKURA Y ET AL: "Constituents and their antioxidative effects in eucalyptus leaf extract used as a natural food additive", FOOD CHEMISTRY 2002 UNITED KINGDOM, vol. 77, no. 1, 2002, pages 47 - 56, XP002467681, ISSN: 0308-8146 * |
BILCHIK T R: "A review of nonvalidated and complementary therapies for cluster headache", CURRENT PAIN AND HEADACHE REPORTS 2004 UNITED KINGDOM, vol. 8, no. 2, 2004, pages 157 - 161, XP008075626, ISSN: 1531-3433 * |
DATABASE WPI Week 199641, Derwent World Patents Index; AN 1996-408323, XP002422394 * |
DATABASE WPI Week 200570, Derwent World Patents Index; AN 2005-680147, XP002422395 * |
DI CARLO G ET AL: "St John's wort: Prozac from the plant kingdom", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER, HAYWARTH, GB, vol. 22, no. 6, 1 June 2001 (2001-06-01), pages 292 - 297, XP004241901, ISSN: 0165-6147 * |
ESCHLER B M ET AL: "Distribution of foliar formylated phloroglucinol derivatives amongst Eucalyptus species", BIOCHEMICAL SYSTEMATICS AND ECOLOGY, vol. 28, no. 9, November 2000 (2000-11-01), pages 813 - 824, XP002422055, ISSN: 0305-1978 * |
GHISALBERTI ET AL: "Bioactive Acylphfluoroglucinol derivatives from Eucalyptus species", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 41, no. 1, 1996, pages 7 - 22, XP002275146, ISSN: 0031-9422 * |
MÜLLER W E ET AL: "Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract", PHARMACOPSYCHIATRY, GEORG THIEME VERLAG, STUTTGART, DE, vol. 31, no. SUPPL 1, June 1998 (1998-06-01), pages 16 - 21, XP002114724, ISSN: 0176-3679 * |
NISHIZAWA M ET AL: "Macrocarpals: HIV-RTase inhibitors of Eucalyptus globulus", TETRAHEDRON LETTERS 1992 UNITED KINGDOM, vol. 33, no. 21, 1992, pages 2983 - 2986, XP002467682, ISSN: 0040-4039 * |
PASS DAVID M ET AL: "Vertebrate herbivory on Eucalyptus-identification of specific feeding deterrents for common ringtail possums (Pseudocheirus peregrinus) by bioassay-guided fractionation of Eucalyptus ovata foliage", JOURNAL OF CHEMICAL ECOLOGY, vol. 24, no. 9, September 1998 (1998-09-01), pages 1513 - 1527, XP002422053, ISSN: 0098-0331 * |
SILVA JEANE ET AL: "Analgesic and anti-inflammatory effects of essential oils of Eucalyptus.", JOURNAL OF ETHNOPHARMACOLOGY, vol. 89, no. 2-3, December 2003 (2003-12-01), pages 277 - 283, XP002422054, ISSN: 0378-8741 * |
TANAKA T ET AL: "First stereoselective total synthesis of macrocarpal C: Structure elucidation of macrocarpal G", CHEMICAL COMMUNICATIONS 21 DEC 1997 UNITED KINGDOM, no. 24, 21 December 1997 (1997-12-21), pages 2401 - 2402, XP002467683, ISSN: 1359-7345 * |
VEROTTA L: "ARE ACYLPHLOROGLUCINOLS LEAD STRUCTURES FOR THE TREATMENT OF DEGENERATIVE DISEASES?", PHYTOCHEMISTRY REVIEWS, KLUWER, NL, vol. 1, 2002, pages 389 - 407, XP008041092, ISSN: 1568-7767 * |
W. FOLEY AND E. LASSAK: "The potential of bioactive constituents of Eucalyptus foliage as non-wood products from plantations", RURAL INDUSTRIES RESEARCH AND DEVELOPMENTAL CORPORATION, November 2004 (2004-11-01), Australia, pages 1 - 43, XP002422056, Retrieved from the Internet <URL:www.rirdc.gov.au/reports/AFT/04-154.pdf> * |
Also Published As
Publication number | Publication date |
---|---|
CN101511378A (zh) | 2009-08-19 |
FR2904557B1 (fr) | 2010-04-30 |
EP2049133A2 (fr) | 2009-04-22 |
FR2904557A1 (fr) | 2008-02-08 |
WO2008017752A2 (fr) | 2008-02-14 |
RU2445112C2 (ru) | 2012-03-20 |
MX2009000673A (es) | 2009-02-04 |
UA99598C2 (ru) | 2012-09-10 |
US20090324754A1 (en) | 2009-12-31 |
AU2007283529A1 (en) | 2008-02-14 |
CA2659162A1 (fr) | 2008-02-14 |
RU2009107166A (ru) | 2010-09-10 |
AR062165A1 (es) | 2008-10-22 |
BRPI0714863A2 (pt) | 2013-05-21 |
TW200820961A (en) | 2008-05-16 |
KR20090034401A (ko) | 2009-04-07 |
TN2009000018A1 (fr) | 2010-08-19 |
NO20090951L (no) | 2009-04-24 |
IL196788A0 (en) | 2009-11-18 |
NZ574429A (en) | 2012-01-12 |
MA30592B1 (fr) | 2009-07-01 |
JP2010500974A (ja) | 2010-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008017752A3 (fr) | Extrait d ' eucalyptus, son procede de preparation et ses utilisations therapeutiques | |
WO2007136518A3 (fr) | Traitement de troubles auto-immunitaires | |
HK1202815A1 (en) | Liquid compositions of calcium acetate | |
WO2009064460A3 (fr) | Systèmes de délivrance aux voies gastro-intestinales | |
WO2006130399A3 (fr) | Combinaisons et methodes therapeutiques comprenant des composes irm | |
WO2005046575A3 (fr) | Prodrogues a base d'acides amines | |
WO2009064388A3 (fr) | Inhibiteurs de la méthionine aminopeptidase humaine 1 et procédés de traitement de troubles | |
MX340822B (es) | Formulaciones para suministro oral de adsorbentes en el intestino. | |
MY145439A (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
WO2006096434A3 (fr) | Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete | |
MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
WO2008023063A3 (fr) | Traitement de maladies du cartilage | |
WO2008011364A3 (fr) | Compositions contenant de la quercétine | |
MY153408A (en) | Novel methods | |
WO2007075923A3 (fr) | Traitement de formes de synucleinopathie | |
WO2007023154A3 (fr) | Utilisation de composes complexes ferriques pour produire un medicament utilise dans le traitement d'etats de deficience ferrique chez des patients atteints de maladie inflammatoire chronique de l'intestin | |
WO2004020403A3 (fr) | Composition et procede accroissant et maintenant la production de neurotransmetteurs | |
ZA200707716B (en) | Use of iron (III) complex compounds | |
WO2007135426A3 (fr) | Traitement de maladies neurodégénératives | |
WO2008094054A3 (fr) | Composés | |
WO2008076296A3 (fr) | Méthode améliorant la fonction de ventilation | |
WO2008037937A3 (fr) | Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme | |
WO2007116428A8 (fr) | Composition pharmaceutique orale contenant de la cystine ou de la cysteine associee a de la glutathione pour la prevention et le traitement du stress oxydant resultant de l'hemodialyse, et dispositif medical pour l'administration de ladite composition | |
WO2008005806A3 (fr) | Procédés, compositions et composés thérapeutiques | |
WO2007092285A3 (fr) | Traitement de synucléinopathies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780033476.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07823364 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/000673 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007823364 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2659162 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 574429 Country of ref document: NZ Ref document number: 602/DELNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12309754 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007283529 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: DZP2009000061 Country of ref document: DZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009522297 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2007283529 Country of ref document: AU Date of ref document: 20070727 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097004185 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: A200901761 Country of ref document: UA |
|
ENP | Entry into the national phase |
Ref document number: 2009107166 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0714863 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090130 |